CF
AVNS

Corebridge Financial’s Avanos Medical AVNS Stock Holding History

Corebridge Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,727
Closed -$340K – 271
2025
Q1 		$340K Sell
23,727
-466
-2% -$7.28K ﹤0.01% 1784
2024
Q4 		$385K Sell
24,193
-1,890
-7% -$37.4K ﹤0.01% 1819
2024
Q3 		$627K Sell
26,083
-274
-1% -$6.26K ﹤0.01% 1612
2024
Q2 		$525K Buy
+26,357
New +$513K ﹤0.01% 1673

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Corebridge Financial's AVNS Position: Q2 2025 in Review

Corebridge Financial sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 23,727 shares — an estimated $340K sold.

Corebridge Financial first reported a position in AVNS in Q2 2024 and held it in 4 quarters. The position peaked at $627K in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Corebridge Financial reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 23,727 Avanos Medical shares in Q2 2025, an estimated $340K.
  • Corebridge Financial first reported a position in Avanos Medical in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Avanos Medical position peaked at $627K in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.